Reps Schrier, Langworthy Introduce Bipartisan Bill to Lower Prescription Drug Costs by Expanding Access to Biosimilars
Drug Administration's (FDA) biosimilar approval process, reduce unnecessary regulatory barriers, and help bring lower-cost prescription drugs … will increase competition, expand patient choice, and help reduce prescription drug costs for families." The legislation would: Clarify